Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

Limited information on salvage treatment in patients affected by pancreatic cancer is available. At failure, about half of the patients present good performance status (PS) and are candidate for further treatment. Patients >18 years, PS ⩾50, with metastatic pancreatic adenocarcinoma previously tr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Reni, M, Pasetto, L, Aprile, G, Cordio, S, Bonetto, E, Dell'oro, S, Passoni, P, Piemonti, L, Fugazza, C, Luppi, G, Milandri, C, Nicoletti, R, Zerbi, A, Balzano, G, Di Carlo, V, Brandes, A A
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2006
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361378/
https://ncbi.nlm.nih.gov/pubmed/16508631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603026
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires